Chemours (NYSE:CC) reported quarterly sales of $1.350 billion which beat the analyst consensus estimate of $1.349 billion by 0.04 percent. This is a 12.11 percent decrease over sales of $1.536 billion the same period last year.
Chemours Q1 Sales $1.350B Beat $1.349B Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.